- Home
- Industry Reports
- Biotechnology
- Healthcare
- Asia Pacific Stem Cell Market – Size, Outlook, Trends, and Forecast (2024 – 2032)
Stem cells are unspecialized cells that can develop into different types of cells which can be of same or different at the earlier stages of life and growth period. The property of forming various new cells has been widely used to treat many diseases and to produce a tissue or organ under conditions. Stem cells can produce cells that can cure diseases like spinal cord injury, diabetes, heart disorders and so on.
Asia Pacific Stem Cells Market Segments Size & Growth:
Asia PacificStem CellsMarket is accounted for $2.71billion in 2017 and expected to grow at a CAGR of 3.9% to reach $6 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth an increasing demand for stem cell therapies, ability to treat various disorders, increase in ageing population, and rise in cancer cases. However, high cost for therapies and legal regulations hinder the growth of the Stem Cells market.
Asia Pacific Stem Cells Market Segments Share:
Asia PacificStem Cells Market is categorised into by treatment type which consists of syngeneic, allogeneic, and autologous The autologous Stem cell therapy has the most significant share due to an increase in chronic diseases. By services, Stem Cells market is segmented as cryopreservation and stem cell banking. Among all stem cell banking are expected to have high growth rate during the forecast period 2018-2024, because of its application in the treatment of diabetes, cancer, autism, and leukaemia. The application is segregated into regenerative medicine, drug discovery and so on.Regenerative medicine is expected to have the most significant share in the market owing strong portfolio for cancer therapy in oncology by renewing the medicine.
By Geography, China is dominating the Stem Cells market, and the growth in the Asia Pacific is mainly attributed because of the increasing demand for personalised medicine and R&D activities. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
Asia Pacific Stem Cells Market Segments Trends:
- New techniques like Cellular barcoding helps the researcher understand the behaviour of stem cells, as they can track and define family tree of individual blood cells in the environment.
- Latest stem cell method sheds light on indicating the sign of heart diseases for the study of vascular diseases.
- In February 2017, Takara Bio Holding, Inc. has wholly acquired WaferGen Bio-Systems, Inc. and has become the subsidiary of TBUSH.
Asia Pacific Stem Cells Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the Asia Pacific diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Cryo-Cell International
- Takara Holdings Inc.
- Stryker Corporation
- BIOTIME, INC.
- Invitrogen
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in population of patients
4.1.2 Stem cells derived from humans
4.1.3 Rise in research on stem cell
4.2 Restraints
4.2.1 High operating cost
4.2.2 Changes in regulations
4.3 Opportunities
4.3.1 Different procedure to cure diseases.
4.3.2 Advancements in personalised medicine and drugs.
4.4 Challenges
4.4.1.Complexities in the functionality of Stem Cell
Chapter 5 Asia-PacificStem Cell Market – By Treatment
5.1 Syngeneic Stem Cell Therapy
5.2 Allogeneic Stem Cell Therapy
5.3 Autologous Stem Cell Therapy
Chapter 6 Asia-PacificStem Cell Market – By Services
6.1 Cryopreservation
6.2 Stem Cell Banking
6.3 Stem Cell Acquisition and testing
Chapter 7 South America Stem Cell Market – By Application
7.1 Regenerative Medicine
7.1.1 Neurology
7.1.2 Oncology
7.1.3 Cardiology
7.1.4 Others
- Drug discovery
7.3 Others
Chapter 8 Asia-PacificStem Cell Market – By Geography
8.1 Introduction
8.2 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.3. South Korea
8.2.5. Australia & New Zealand
8.2.6. Rest of APAC
Chapter 9 Asia-PacificStem Cell Market – Company Profiles
9.1. Aastrom bioscience
9.2.Cytori Therapeutics, Inc.
9.3.Ocata Therapeutics
9.4.Geron Corporation
9.5. Athersys Inc.,
9.6.StemCells, Inc.
9.7.Cryo-Cell International
9.8.Invitrogen
9.9.Thermo fisher scientific Pvt. Ltd
9.10.Beckton Dickinson and company
9.11.Takara Holdings Inc.
9.12. Stryker Corporation
9.13.GE Healthcare
9.14.Fujifilm Inc.
9.15. BIOTIME, INC.
Chapter 10Asia-PacificStem Cell Market – Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,016.05 - €6,720.18
- INR: ₹180,072.11 - ₹600,240.36
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,726.61 - £5,755.36
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Stem cells are unspecialized cells that can develop into different types of cells which can be of same or different at the earlier stages of life and growth period. The property of forming various new cells has been widely used to treat many diseases and to produce a tissue or organ under conditions. Stem cells can produce cells that can cure diseases like spinal cord injury, diabetes, heart disorders and so on.
Asia Pacific Stem Cells Market Segments Size & Growth:
Asia PacificStem CellsMarket is accounted for $2.71billion in 2017 and expected to grow at a CAGR of 3.9% to reach $6 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth an increasing demand for stem cell therapies, ability to treat various disorders, increase in ageing population, and rise in cancer cases. However, high cost for therapies and legal regulations hinder the growth of the Stem Cells market.
Asia Pacific Stem Cells Market Segments Share:
Asia PacificStem Cells Market is categorised into by treatment type which consists of syngeneic, allogeneic, and autologous The autologous Stem cell therapy has the most significant share due to an increase in chronic diseases. By services, Stem Cells market is segmented as cryopreservation and stem cell banking. Among all stem cell banking are expected to have high growth rate during the forecast period 2018-2024, because of its application in the treatment of diabetes, cancer, autism, and leukaemia. The application is segregated into regenerative medicine, drug discovery and so on.Regenerative medicine is expected to have the most significant share in the market owing strong portfolio for cancer therapy in oncology by renewing the medicine.
By Geography, China is dominating the Stem Cells market, and the growth in the Asia Pacific is mainly attributed because of the increasing demand for personalised medicine and R&D activities. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
Asia Pacific Stem Cells Market Segments Trends:
- New techniques like Cellular barcoding helps the researcher understand the behaviour of stem cells, as they can track and define family tree of individual blood cells in the environment.
- Latest stem cell method sheds light on indicating the sign of heart diseases for the study of vascular diseases.
- In February 2017, Takara Bio Holding, Inc. has wholly acquired WaferGen Bio-Systems, Inc. and has become the subsidiary of TBUSH.
Asia Pacific Stem Cells Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the Asia Pacific diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Cryo-Cell International
- Takara Holdings Inc.
- Stryker Corporation
- BIOTIME, INC.
- Invitrogen
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in population of patients
4.1.2 Stem cells derived from humans
4.1.3 Rise in research on stem cell
4.2 Restraints
4.2.1 High operating cost
4.2.2 Changes in regulations
4.3 Opportunities
4.3.1 Different procedure to cure diseases.
4.3.2 Advancements in personalised medicine and drugs.
4.4 Challenges
4.4.1.Complexities in the functionality of Stem Cell
Chapter 5 Asia-PacificStem Cell Market – By Treatment
5.1 Syngeneic Stem Cell Therapy
5.2 Allogeneic Stem Cell Therapy
5.3 Autologous Stem Cell Therapy
Chapter 6 Asia-PacificStem Cell Market – By Services
6.1 Cryopreservation
6.2 Stem Cell Banking
6.3 Stem Cell Acquisition and testing
Chapter 7 South America Stem Cell Market – By Application
7.1 Regenerative Medicine
7.1.1 Neurology
7.1.2 Oncology
7.1.3 Cardiology
7.1.4 Others
- Drug discovery
7.3 Others
Chapter 8 Asia-PacificStem Cell Market – By Geography
8.1 Introduction
8.2 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.3. South Korea
8.2.5. Australia & New Zealand
8.2.6. Rest of APAC
Chapter 9 Asia-PacificStem Cell Market – Company Profiles
9.1. Aastrom bioscience
9.2.Cytori Therapeutics, Inc.
9.3.Ocata Therapeutics
9.4.Geron Corporation
9.5. Athersys Inc.,
9.6.StemCells, Inc.
9.7.Cryo-Cell International
9.8.Invitrogen
9.9.Thermo fisher scientific Pvt. Ltd
9.10.Beckton Dickinson and company
9.11.Takara Holdings Inc.
9.12. Stryker Corporation
9.13.GE Healthcare
9.14.Fujifilm Inc.
9.15. BIOTIME, INC.
Chapter 10Asia-PacificStem Cell Market – Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.